Aurigene Pharmaceutical Services Ltd, a wholly owned subsidiary of Dr Reddy’s Laboratories, has entered into a long-term manufacturing and supply agreement with an undisclosed global pharmaceutical company.

Under the agreement, Aurigene will undertake commercial drug-product manufacturing and supply across a diversified portfolio for markets including the US, Europe, Canada and emerging economies.

The company, which operates as a contract research, development and manufacturing organisation (CRDMO), said the identity of the partner has not been disclosed due to confidentiality obligations under the agreement.